Compounds > aminoimidazole carboxamide
Page last updated: 2024-08-21

aminoimidazole carboxamide and Thyroid Neoplasms

aminoimidazole carboxamide has been researched along with Thyroid Neoplasms in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abbonante, V; Awwad, O; Balduini, A; Chiovato, L; Coperchini, F; Croce, L; Denegri, M; Di Buduo, CA; Massara, S; Pignatti, P; Rotondi, M1
Choi, HJ; Kim, TY; Kim, WB; Kim, WG; Shong, YK1
Andrade, BM; Carvalho, DP; Cazarin, JM; Coelho, RG; Hecht, F1
Choi, HJ; Chung, N; Kim, JA; Kim, TY; Kim, WB; Kim, WG; Shong, YK; Yim, JH1

Other Studies

4 other study(ies) available for aminoimidazole carboxamide and Thyroid Neoplasms

ArticleYear
The AMPK-activator AICAR in thyroid cancer: effects on CXCL8 secretion and on CXCL8-induced neoplastic cell migration.
    Journal of endocrinological investigation, 2018, Volume: 41, Issue:11

    Topics: Aminoimidazole Carboxamide; Cell Line, Tumor; Cell Movement; Cell Proliferation; Humans; Interleukin-8; Ribonucleotides; Thyroid Gland; Thyroid Neoplasms; Tumor Necrosis Factor-alpha

2018
The effect of 5-aminoimidazole-4-carboxamide-ribonucleoside was mediated by p38 mitogen activated protein kinase signaling pathway in FRO thyroid cancer cells.
    The Korean journal of internal medicine, 2014, Volume: 29, Issue:4

    Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Antineoplastic Agents; Caspase 3; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cyclin-Dependent Kinase Inhibitor p21; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Activators; Humans; Mutation; p38 Mitogen-Activated Protein Kinases; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Ribonucleotides; RNA Interference; Signal Transduction; Thyroid Neoplasms; Time Factors; Transfection

2014
5'-AMP-Activated Protein Kinase Regulates Papillary (TPC-1 and BCPAP) Thyroid Cancer Cell Survival, Migration, Invasion, and Epithelial-to-Mesenchymal Transition.
    Thyroid : official journal of the American Thyroid Association, 2016, Volume: 26, Issue:7

    Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Apoptosis; Carcinoma, Papillary; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Epithelial-Mesenchymal Transition; G1 Phase Cell Cycle Checkpoints; G2 Phase Cell Cycle Checkpoints; Humans; Neoplasm Invasiveness; Ribonucleotides; Thyroid Cancer, Papillary; Thyroid Neoplasms

2016
The influence of the BRAF V600E mutation in thyroid cancer cell lines on the anticancer effects of 5-aminoimidazole-4-carboxamide-ribonucleoside.
    The Journal of endocrinology, 2011, Volume: 211, Issue:1

    Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinase Kinases; Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Energy Metabolism; Humans; Mutation; Protein Kinases; Proto-Oncogene Proteins B-raf; Ribonucleotides; Signal Transduction; Thyroid Neoplasms; Treatment Outcome

2011